Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

HEXO Corp.

HEXONASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.71
$0.02(2.45%)
U.S. Market is Open • 14:23

HEXO Corp. (HEXO) Stock Overview

Explore HEXO Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap31.2M
P/E Ratio-0.03
EPS (TTM)$-2.77
ROE-2.06%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

HEXO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of HEXO Corp. (HEXO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.03 and a market capitalization of 31.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-39.83%
6-Month Change
-52.67%
Year-to-Date (YTD) Change
-29.70%
1-Year Change
-74.30%
3-Year Change
-98.23%
5-Year Change
-99.62%
All-Time (Max) Change
-99.15%

Contact Information

18444061852
120 Chemin de la Rive, Gatineau, QC, NaN

Company Facts

IPO DateMar 23, 2017
CountryCA

Frequently Asked Questions